News & Updates

Show Multimedia Only
Antiviral therapy lowers HCC risk in indeterminate CHB phase
Antiviral therapy lowers HCC risk in indeterminate CHB phase
27 May 2025 byStephen Padilla

Patients with chronic hepatitis B (CHB) in the indeterminate phase are predisposed to advanced liver disease and hepatocellular carcinoma (HCC), as shown by a systematic review and meta-analysis.

Antiviral therapy lowers HCC risk in indeterminate CHB phase
27 May 2025
TrUST study heralds new era for TB diagnosis
TrUST study heralds new era for TB diagnosis
21 May 2025 byAudrey Abella

A suite of deep learning (DL) models to automate tuberculosis (TB) risk assessment from lung ultrasound (LUS) images fulfils the WHO criteria for a sputum-free TB triage test and outwits human experts in the TrUST study.

TrUST study heralds new era for TB diagnosis
21 May 2025
Meta-analysis strengthens case for awake prone positioning in COVID-19 with AHRF
Meta-analysis strengthens case for awake prone positioning in COVID-19 with AHRF
17 May 2025 byJairia Dela Cruz

Placing awake COVID-19 patients with acute hypoxaemic respiratory failure (AHRF) in a prone position is an efficacious intervention in terms of both reducing mortality and preventing intubation, according to an individual participant data meta-analysis.

Meta-analysis strengthens case for awake prone positioning in COVID-19 with AHRF
17 May 2025
5-day antibiotic use viable in CAP patients with clinical stability
5-day antibiotic use viable in CAP patients with clinical stability
16 May 2025